InsiderClue
Insiders · Profile

Artal International S.C.A.

Director at CAVA · Director at LEXICON PHARMACEUTICALS · 10% owner at Scholar Rock. Filing since 23 Oct 2012. CIK 0001218180

CAVA CAVA GROUP, INC. Director · 5 trades LXRX LEXICON PHARMACEUTICALS, INC. Director · 6 trades SRRK Scholar Rock Holding Corp 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
CAVA CAVA GROUP, INC.
18 Nov 2024
Director
Sold at will
8,000,000
$1.07B
45.7%
CAVA CAVA GROUP, INC.
26 Aug 2024
Director
Sold at will
6,000,000
$698.16M
25.5%
CAVA CAVA GROUP, INC.
5 Jun 2024
Director
Sold at will
3,000,000
$261.75M
11.3%
CAVA CAVA GROUP, INC.
21 Mar 2024
Director
Sold at will
2,000,000
$132.50M
7.0%
CAVA CAVA GROUP, INC.
27 Feb 2024
Director
Sold at will
3,500,000
$187.60M
10.9%
LXRX LEXICON PHARMACEUTICALS, INC.
5 Jun 2023
Director
Bought
27,775,050
$72.22M
54.6%
LXRX LEXICON PHARMACEUTICALS, INC.
5 Aug 2022
Director
Bought
2,426,070
$6.07M
5.0%
LXRX LEXICON PHARMACEUTICALS, INC.
1 Aug 2022
Director
Bought
16,173,800
$40.43M
50.1%
LXRX LEXICON PHARMACEUTICALS, INC.
16 Dec 2020
Director
Bought
10,937,500
$35.00M
51.3%
SRRK Scholar Rock Holding Corp
29 May 2018
10% owner
Bought
450,000
$6.30M
opened
LXRX LEXICON PHARMACEUTICALS, INC.
26 Nov 2014
Director
Bought
149,253,731
$150.00M
opened
LXRX LEXICON PHARMACEUTICALS, INC.
23 Oct 2012
Director
Bought
3,000,000
$6.75M
1.1%
12 decisions on file.